TLPH (STOCKS)
Talphera, Inc. Common Stock
$0.885300
+0.011900 (+1.36%)
Prev close: $0.873400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Vincent J. Angotti
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45.68M
- Employees
- 13
- P/E (TTM)
- -2.94
- P/B (TTM)
- 2.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.04 | $-0.07 | +0.0314 | +43.98% |
|
Dec 2025 (Q4)
|
$-0.06 | $-0.08 | +0.0216 | +26.47% |
|
Sep 2025 (Q3)
|
$-0.11 | $-0.14 | +0.0328 | +22.97% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.10 | +0.0020 | +1.96% |
Financial Statements
| Revenues | $1.00K |
| Costs And Expenses | $14.52M |
| Nonoperating Income/Loss | $263.00K |
| Selling, General, and Administrative Expenses | $8.00M |
| Research and Development | $6.51M |
| Operating Income/Loss | -$14.52M |
| Income/Loss From Continuing Operations After Tax | -$14.25M |
| Income/Loss From Continuing Operations Before Tax | -$14.25M |
| Income/Loss From Discontinued Operations Net Of Tax | $0.00 |
| Net Income/Loss | -$14.25M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$14.25M |
| Net Income/Loss Available To Common Stockholders, Basic | -$14.25M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.28 |
| Basic Average Shares | 154,076,450 |
| Assets | $30.16M |
| Current Assets | $21.34M |
| Cash | $21.11M |
| Other Current Assets | $228.00K |
| Noncurrent Assets | $8.82M |
| Intangible Assets | $8.82M |
| Liabilities | $11.68M |
| Current Liabilities | $4.03M |
| Accounts Payable | $927.00K |
| Other Current Liabilities | $3.10M |
| Noncurrent Liabilities | $7.65M |
| Equity | $18.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $18.48M |
| Liabilities And Equity | $30.16M |
| Net Cash Flow From Operating Activities | -$11.29M |
| Net Cash Flow From Operating Activities, Continuing | -$11.29M |
| Net Cash Flow From Investing Activities | -$20.53M |
| Net Cash Flow From Investing Activities, Continuing | -$20.53M |
| Net Cash Flow From Financing Activities | $26.79M |
| Net Cash Flow From Financing Activities, Continuing | $26.79M |
| Net Cash Flow | -$5.04M |
| Net Cash Flow, Continuing | -$5.04M |
| Comprehensive Income/Loss | -$14.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$14.25M |
| Other Comprehensive Income/Loss | $0.00 |